Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 14, 2026
Total Value: $1.936B (98.5% shares, 1.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | STATE STR SPDR S&P 500 ETF T | 200,000 | $130M | 6.7% | — | — | Put | 78462F103 |
| APGE | APOGEE THERAPEUTICS INC | 1,284,926 | $108M | 5.6% | $40.18 | +79.8% | COM | 03770N101 |
| XENE | XENON PHARMACEUTICALS INC | 1,675,000 | $97.4M | 5.0% | $39.93 | +5.2% | COM | 98420N105 |
| ERAS | ERASCA INC | 5,350,000 | $86.56M | 4.5% | $4.10 | +144.3% | COM | 29479A108 |
| INSM | INSMED INC | 480,000 | $78.49M | 4.1% | $77.91 | +104.1% | COM PAR $.01 | 457669307 |
| ROIV | ROIVANT SCIENCES LTD | 2,800,000 | $77.56M | 4.0% | $19.15 | +26.2% | SHS | G76279101 |
| SYRE | SPYRE THERAPEUTICS INC | 1,279,134 | $64.52M | 3.3% | $18.18 | +89.9% | COM NEW | 00773J202 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,400,000 | $55.61M | 2.9% | $27.87 | — | SPONSORED ADS | 152309100 |
| PRAX | PRAXIS PRECISION MEDICINES I | 170,000 | $54.77M | 2.8% | $186.22 | +67.4% | COM NEW | 74006W207 |
| ANAB | ANAPTYSBIO INC | 940,000 | $52.13M | 2.7% | $44.45 | +11.1% | COM | 032724106 |
| ALKS | ALKERMES PLC | 1,350,000 | $47.74M | 2.5% | $27.82 | +16.2% | SHS | G01767105 |
| CYTK | CYTOKINETICS INC | 700,483 | $46.17M | 2.4% | $53.01 | +21.6% | COM NEW | 23282W605 |
| ABVX | ABIVAX SA | 405,000 | $45.1M | 2.3% | $83.67 | — | SPONSORED ADS | 00370M103 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $42.17M | 2.2% | $8.35 | — | SPONSORED ADS | 881624209 |
| ACLX | ARCELLX INC | 362,764 | $41.65M | 2.2% | $46.50 | +53.3% | COMMON STOCK | 03940C100 |
| MRNA | MODERNA INC | 800,000 | $40.64M | 2.1% | — | — | Call | 60770K107 |
| NUVL | NUVALENT INC | 300,000 | $30.73M | 1.6% | $72.88 | +42.2% | COM | 670703107 |
| TERN | TERNS PHARMACEUTICALS INC | 562,631 | $29.66M | 1.5% | $23.43 | +59.9% | COM | 880881107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 350,000 | $29.37M | 1.5% | $40.34 | +17.9% | COM | 252828108 |
| LXEO | LEXEO THERAPEUTICS INC | 5,050,211 | $28.99M | 1.5% | $5.19 | +45.1% | COM | 52886X107 |
| COGT | COGENT BIOSCIENCES INC | 750,000 | $28.87M | 1.5% | $33.05 | +13.1% | COM | 19240Q201 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 55,000 | $28.79M | 1.5% | $336.27 | +46.5% | COM | 558868105 |
| STRO | SUTRO BIOPHARMA INC | 1,069,519 | $26.64M | 1.4% | $11.17 | +35.0% | COM SHS | 869367201 |
| FBRX | FORTE BIOSCIENCES INC | 1,011,890 | $26.21M | 1.4% | $17.80 | +66.7% | COM NEW | 34962G208 |
| ORKA | ORUKA THERAPEUTICS INC | 499,673 | $24.51M | 1.3% | $21.60 | +50.3% | COM | 687604108 |
| TRVI | TREVI THERAPEUTICS INC | 2,000,172 | $23.86M | 1.2% | $5.69 | +92.1% | COM | 89532M101 |
| OVID | OVID THERAPEUTICS INC | 10,636,318 | $23.61M | 1.2% | $1.37 | +16.0% | COM | 690469101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 586,904 | $23.01M | 1.2% | $25.60 | 0.0% | COM | 29337E102 |
| ASND | ASCENDIS PHARMA A/S | 95,000 | $21.73M | 1.1% | $223.84 | — | SPONSORED ADR | 04351P101 |
| MLYS | MINERALYS THERAPEUTICS INC | 750,000 | $20.32M | 1.0% | $12.29 | +155.2% | COM | 603170101 |
| AVTX | AVALO THERAPEUTICS INC | 1,340,840 | $20.02M | 1.0% | $11.11 | +39.5% | COM NEW | 05338F306 |
| BMY | BRISTOL-MYERS SQUIBB CO | 300,000 | $18.2M | 0.9% | — | — | Call | 110122108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 172,125 | $18.14M | 0.9% | $81.85 | +1.8% | COM | 74366E102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 500,000 | $15.86M | 0.8% | $24.16 | +5.2% | COM NEW | 15117B202 |
| ZURA | ZURA BIO LTD | 2,564,303 | $15.26M | 0.8% | $3.60 | +63.5% | CLASS A ORD SHS | G9TY5A101 |
| NRIX | NURIX THERAPEUTICS INC | 967,620 | $15M | 0.8% | $10.44 | +66.1% | COM | 67080M103 |
| SVRA | SAVARA INC | 2,512,153 | $13.72M | 0.7% | $3.81 | +49.2% | COM | 805111101 |
| — | OMEROS CORP | 6,525,000 | $13.22M | 0.7% | $1.12 | — | NOTE 9.500% 6/1 | 682143AK8 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 3,164,582 | $13.2M | 0.7% | $4.18 | -8.1% | COM NEW | 46489V302 |
| HLXC | HELIX ACQUISITION CORP III | 1,250,000 | $12.7M | 0.7% | $10.16 | — | USD CL A ORD SHS | G4444S107 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 200,000 | $12.54M | 0.6% | $59.88 | +9.8% | COM | 04280A100 |
| GLTO | DAMORA THERAPEUTICS INC | 450,000 | $11.65M | 0.6% | $25.80 | 0.0% | COM NEW | 36322Q206 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,589,005 | $11.5M | 0.6% | $7.82 | +7.1% | COM | 29842P105 |
| ANRO | ALTO NEUROSCIENCE INC | 500,000 | $11.24M | 0.6% | $16.77 | 0.0% | COM SHS | 02157Q109 |
| BBIO | BRIDGEBIO PHARMA INC | 150,000 | $11.14M | 0.6% | $58.10 | +28.2% | COM | 10806X102 |
| CGEM | CULLINAN THERAPEUTICS INC | 781,260 | $11.1M | 0.6% | $9.03 | +32.5% | COM | 230031106 |
| BLTE | BELITE BIO INC | 65,000 | $10.36M | 0.5% | $159.60 | — | SPONSORED ADS | 07782B104 |
| WVE | WAVE LIFE SCIENCES LTD | 1,401,727 | $10.16M | 0.5% | $7.78 | +76.7% | SHS | Y95308105 |
| VERA | VERA THERAPEUTICS INC | 250,000 | $10.06M | 0.5% | $31.26 | +43.9% | CL A | 92337R101 |
| TYRA | TYRA BIOSCIENCES INC | 257,512 | $9.863M | 0.5% | $30.25 | 0.0% | COM | 90240B106 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $9.725M | 0.5% | $39.15 | +163.1% | Put | 76155X100 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $9.725M | 0.5% | $39.15 | +163.1% | COM | 76155X100 |
| IBRX | IMMUNITYBIO INC | 1,250,000 | $9.588M | 0.5% | — | — | Put | 45256X103 |
| JBIO | JADE BIOSCIENCES INC | 639,956 | $8.991M | 0.5% | $13.70 | +7.9% | COM NEW | 008064206 |
| TVTX | TRAVERE THERAPEUTICS INC | 300,000 | $8.913M | 0.5% | $19.81 | +56.6% | COM | 89422G107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 275,000 | $8.803M | 0.5% | $17.93 | +88.2% | ORDINARY SHARES | N62509109 |
| — | COGENT BIOSCIENCES INC | 7,000,000 | $8.585M | 0.4% | $1.22 | — | NOTE 1.625%11/1 | 19240QAA0 |
| KRRO | KORRO BIO INC | 706,904 | $8.002M | 0.4% | $10.79 | 0.0% | COM | 500946108 |
| — | CELCUITY INC | 3,000,000 | $7.314M | 0.4% | $1.33 | — | NOTE 2.750% 8/0 | 15102KAA8 |
| CRSP | CRISPR THERAPEUTICS AG | 150,000 | $7.136M | 0.4% | $53.50 | 0.0% | NAMEN AKT | H17182108 |
| SGP | SPYGLASS PHARMA INC | 250,000 | $6.478M | 0.3% | $25.91 | — | COM SHS | 85220G109 |
| NVO | NOVO-NORDISK A S | 175,000 | $6.431M | 0.3% | — | — | Call | 670100205 |
| CMPS | COMPASS PATHWAYS PLC | 1,108,483 | $6.13M | 0.3% | $5.57 | — | SPONSORED ADS | 20451W101 |
| IBIO | IBIO INC | 3,107,200 | $5.904M | 0.3% | $1.69 | +37.3% | COM NEW | 451033708 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 100,000 | $5.678M | 0.3% | $53.71 | +30.9% | COM | G31249108 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 912,397 | $5.064M | 0.3% | $5.53 | +1.0% | COM | 03675P102 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 245,000 | $4.91M | 0.3% | $6.02 | — | *W EXP 99/99/999 | N62509117 |
| QURE | UNIQURE NV | 300,000 | $4.905M | 0.3% | $16.30 | +44.5% | Call | N90064101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 250,000 | $4.89M | 0.3% | $16.46 | +87.4% | COM | 92790C104 |
| CLYM | CLIMB BIO INC | 700,000 | $4.795M | 0.2% | $3.30 | +51.4% | COM | 28658R106 |
| RZLT | REZOLUTE INC | 1,547,641 | $4.72M | 0.2% | $2.90 | +5.7% | COM NEW | 76200L309 |
| SGMT | SAGIMET BIOSCIENCES INC | 868,020 | $4.535M | 0.2% | $7.47 | -22.2% | COM SER A | 786700104 |
| MBX | MBX BIOSCIENCES INC | 150,000 | $4.478M | 0.2% | $17.07 | +115.7% | COM | 55287L101 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,000,000 | $4.47M | 0.2% | $2.98 | +60.0% | COM SHS | 877619106 |
| MANE | VERADERMICS INC | 70,000 | $4.42M | 0.2% | $63.15 | — | COMMON STOCK | 922967104 |
| GENB | GENERATE BIOMEDICINES INC | 350,000 | $4.375M | 0.2% | $12.50 | — | COM SHS | 370920100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 50,000 | $4.196M | 0.2% | $40.34 | +17.9% | Call | 252828108 |
| ENGN | ENGENE HOLDINGS INC | 610,370 | $4.157M | 0.2% | $7.50 | +28.8% | COM | 29286M105 |
| CGON | CG ONCOLOGY INC | 60,000 | $4.061M | 0.2% | — | — | Call | 156944100 |
| AVBP | ARRIVENT BIOPHARMA INC | 175,000 | $4.037M | 0.2% | $20.99 | +5.1% | COM | 04272N102 |
| RLAY | RELAY THERAPEUTICS INC | 400,000 | $3.98M | 0.2% | $8.30 | 0.0% | COM | 75943R102 |
| PRQR | PROQR THRAPEUTICS N V | 2,454,278 | $3.976M | 0.2% | $2.92 | -44.1% | SHS EURO | N71542109 |
| VRCA | VERRICA PHARMACEUTICALS INC | 707,338 | $3.742M | 0.2% | $5.54 | +26.6% | COM SHS | 92511W207 |
| CELC | CELCUITY INC | 30,000 | $3.424M | 0.2% | — | — | Call | 15102K100 |
| DTIL | PRECISION BIOSCIENCES INC | 597,946 | $3.289M | 0.2% | $4.00 | 0.0% | COM NEW | 74019P207 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 500,000 | $2.785M | 0.1% | $6.12 | +24.6% | COM NEW | 48576U205 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 35,000 | $2.773M | 0.1% | $66.40 | 0.0% | SHS NEW | M8694L137 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 75,000 | $2.724M | 0.1% | $27.88 | +76.5% | COM | 22663K107 |
| OACCU | OAKTREE ACQUISITION CORP III | 250,000 | $2.663M | 0.1% | $10.15 | — | UNIT 10/04/2029 | G6717R120 |
| NXTC | NEXTCURE INC | 241,826 | $2.583M | 0.1% | $6.38 | +97.1% | COM NEW | 65343E207 |
| IMVT | IMMUNOVANT INC | 100,000 | $2.484M | 0.1% | $16.19 | +62.2% | COM | 45258J102 |
| EQ | EQUILLIUM INC | 1,226,310 | $2.453M | 0.1% | $1.44 | 0.0% | COM | 29446K106 |
| SABS | SAB BIOTHERAPEUTICS INC | 575,000 | $2.202M | 0.1% | $4.00 | 0.0% | COM NEW | 78397T202 |
| CORT | CORCEPT THERAPEUTICS INC | 50,000 | $2.015M | 0.1% | $38.80 | 0.0% | COM | 218352102 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 402,550 | $1.711M | 0.1% | $2.76 | +49.5% | COM | 68572M106 |
| KZR | KEZAR LIFE SCIENCES INC | 229,076 | $1.7M | 0.1% | $5.83 | +8.0% | COM NEW | 49372L209 |
| MGNX | MACROGENICS INC | 500,000 | $1.445M | 0.1% | $1.58 | +11.8% | COM | 556099109 |
| ANL | ADLAI NORTYE LTD | 164,748 | $1.14M | 0.1% | $6.92 | — | SPONSORED ADS | 00704R109 |
| ALEC | ALECTOR INC | 500,000 | $1.075M | 0.1% | $1.91 | 0.0% | COM | 014442107 |
| OKUR | ONKURE THERAPEUTICS INC | 240,963 | $998K | 0.1% | $2.73 | 0.0% | COM CL A | 68277Q105 |
| LENZ | LENZ THERAPEUTICS INC | 100,000 | $915K | 0.0% | $15.73 | 0.0% | COM | 52635N103 |
| XFOR | X4 PHARMACEUTICALS INC | 145,000 | $599K | 0.0% | $3.63 | +0.1% | COM NEW | 98420X202 |
| QTTB | Q32 BIO INC | 27,777 | $178K | 0.0% | $13.78 | -71.4% | COM | 746964105 |
| ADGM | ADAGIO MED HLDGS INC | 80,000 | $92,000 | 0.0% | $4.76 | -79.4% | COM | 00534B100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $1,178 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |